EditForce

company

About

EditForce develops drugs and seeds by using nucleic acid manipulation technologies.

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
¥800M
Industries
Biotechnology,Medical,Nursing and Residential Care
Founded date
May 15, 2015
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
EditForce Inc., Edit Force Co., Ltd.

EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
¥1.84B
EditForce has raised a total of ¥1.84B in funding over 2 rounds. Their latest funding was raised on May 26, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 26, 2021 Series Unknown ¥800M 4 Newton Biocapital — Detail
Mar 1, 2019 Series B ¥870M 6 — — Detail
Feb 3, 2016 Seed ¥175M 2 UTEC - The University of Tokyo Edge Capital Partners — Detail

Employee Profiles

Number of Employee Profiles
10
EditForce has 10 current employee profiles, including Board member Tomotaka Goji
Board member
Board member
Executive
Board member